Effect of baclofen on esophagogastric motility and gastroesophageal reflux in children with gastroesophageal reflux disease: A randomized controlled trial

Journal of Pediatrics

Volumn 149, Issue 4, 2006, Pages

  Omari, Taher I ^a   Benninga, Marc A ^a   Sansom, Lloyd ^a   Butler, Ross N ^a   Dent, John ^a   Davidson, Geoffrey P ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; PLACEBO;

ADOLESCENT; ARTICLE; BREATH ANALYSIS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; EPISTAXIS; ESOPHAGUS MOTILITY; FATIGUE; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; IRRITABILITY; LOWER ESOPHAGUS SPHINCTER PRESSURE; MALE; MANOMETRY; MILK; NAUSEA; PH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH EMPTYING; VOMITING;

EID: 33748977207     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2006.05.029     Document Type: Article

References (35)

1. Holloway R., and Dent J. Pathophysiology of gastroesophageal reflux: lower esophageal sphincter dysfunction in gastroesophageal reflux disease. Gastroenterol Clin North Am 19 (1990) 517-535
2. Holloway R., Kocyan P., and Dent J. Provocation of transient lower esophageal sphincter relaxations by meals in patients with symptomatic gastroesophageal reflux. Dig Dis Sci 36 (1991) 1034-1039
3. Werlin S., Dodds W., Hogan W., and Arndorfer R. Mechanisms of gastroesophageal reflux in children. J Paediatr 97 (1980) 244-249
4. Cucchiara S., Bortolotti M., Minella R., and Auricchio S. Fasting and postprandial mechanisms of gastroesophageal reflux in children with gastroesophageal reflux. Dig Dis Sci 38 (1993) 86-92
5. Kawahara H., Dent J., and Davidson G.P. Evaluation of the mechanisms responsible for gastroesophageal reflux in children. Gastroenterology 113 (1997) 399-408
6. Omari T.I., Barnett C., Snel A., Goldsworthy W., Haslam R., Davidson G., et al. Mechanisms of gastro-oesophageal reflux in healthy premature infants. J Pediatr 133 (1998) 650-654
7. Omari T.I., Barnett C.P., Benninga M.A., Lontis R., Goodchild L., Haslam R.R., et al. Mechanisms of gastro-oesophageal reflux in preterm and term infants with reflux disease. Gut 51 (2002) 475-479
8. Lehmann A., Antonsson M., Bremner-Danieisen M., Hansson-Brändén L., and Kärrberg L. Activation of the GABA(B) receptor inhibits transient lower esophageal sphincter relaxation in dogs. Gastroenterology 117 (1999) 1147-1154
9. Blackshaw L., Staunton E., Lehmann A., and Dent J. Inhibition of transient LES relaxation and reflux in ferrets by GABA receptor agonists. Am J Physiol 277 (1999) G867-G874
10. Staunton E., Smid S.D., Dent J., and Blackshaw L.A. Triggering of transient LES relaxation in ferrets: role of sympathetic pathways and effects of baclofen. Am J Physiol Gastrointest Liver Physiol 279 (2000) G157-G162
11. Lidums I., Lehmann A., Checklin H., Dent J., and Holloway R. Control of transient lower esophageal sphincter relaxation and reflux by the GABA(B) agonist baclofen in normal subjects. Gastroenterology 118 (2000) 7-13
12. Zhang Q., Lehmann A., Rigda R., Dent J., and Holloway R.H. Control of transient lower oesophageal sphincter relaxation and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease. Gut 50 (2002) 19-24
13. van Herwaarden M.A., Samsom M., Rydholm H., and Smout A.J. The effect of baclofen on gastro-oesophageal reflux, lower oesophageal sphincter function and reflux symptoms in patients with reflux disease. Aliment Pharmacol Ther 16 (2002) 1655-1662
14. Koek G.H., Sifrim D., Lerut T., Janssens J., and Tack J. Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors. Gut 52 (2003) 1397-1402
15. Ciccaglione A.F., and Marzio L. Effect of acute and chronic administration of the GABA B agonist baclofen on 24-hour pHmetry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease. Gut 52 (2003) 464-470
16. Vela M.F., Tutuian R., Katz P.O., and Castell D.O. Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH. Aliment Pharmacol Ther 17 (2003) 243-251
17. Cange L., Johnsson E., Rydholm H., Lehmann A., Finizia C., Lundell L., et al. Baclofen-mediated gastro-oesophageal acid reflux control in patients with established reflux disease. Aliment Pharmacol Ther 16 (2002) 869-873
18. Kawai M., Kawahara H., Hirayama S., Yoshimura N., and Ida S. Effect of baclofen on emesis and 24-hour esophageal pH in neurologically impaired children with gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 38 (2004) 317-323
19. Wiersma H.E., van Boxtel C.J., Butter J.J., van Aalderen W.M.C., Omari T., and Benninga M. Pharmacokinetics of a single dose of baclofen in pediatric patients with gastroesophageal reflux disease. Ther Drug Monit 25 (2003) 93-98
20. Holloway R.H., Penagini R., and Ireland A.C. Criteria for objective definition of transient lower esophageal sphincter relaxation. Am J Physiol 268 (1995) G128-G133
21. Barnett C., Snel A., Omari T., Davidson G., Haslam R., and Butler R. Reproducibility of the 13C-octanoic acid breath test for assessment of gastric emptying in healthy preterm infants. J Pediatr Gastroenterol Nutr 29 (1999) 26-30
22. Van Den Driessche M. Study of gastrointestinal motility in infants and children using 13C breath tests (2001), Leuven University [doctoral thesis]
23. Page A., and Blackshaw L. GABA(B) receptors inhibit mechanosensitivity of primary afferent endings. J. Neurosci 19 (1999) 8597-8602
24. Partosoedarso E., Young R., and Blackshaw L. GABA(B) receptors on vagal afferent pathways: peripheral and central inhibition. Am J Physiol 280 (2001) G658-G668
25. Smid S., and Blackshaw L. Vagal neurotransmission to the ferret lower oesophageal sphincter: inhibition via GABA(B) receptors. Br J Pharmacol 131 (2000) 624-630
26. Blackshaw L., Smid S., O'Donnell T., and Dent J. GABA(B) receptor-mediated effects on vagal pathways to the lower oesophageal sphincter and heart. Br J Pharmacol 130 (2000) 279-288
27. Browning K., and Travagli R. Mechanism of action of baclofen in rat dorsal motor nucleus of the vagus. Am J Physiol 280 (2001) G1106-G1113
28. McDermott C., Abrahams T., Partosoedarso E., Hyland N., Ekstrand J., Monroe M., et al. Site of action of GABA B receptors for vagal motor control of the lower esophageal spincter in ferrets and rats. Gastroenterology 120 (2001) 1749-1762
29. Symonds E., Butler R., and Omari T. The effect of the GABA B receptor agonist baclofen on liquid and solid gastric emptying in mice. Eur J Pharmacol 470 (2003) 95-97
30. Monroe M., and Hornby P. Baclofen decreases intragastric volume measured by novel miniaturized barostat in decerebrated mice. Gastroenterology 122 (2002) A557
31. Andrews P., Bingham S., and Wood K. Modulation of the vagal drive to the intramural cholinergic and non-cholinergic neurones in the ferret stomach by baclofen. J Physiol 388 (1987) 25-39
32. Fargeas M., Fioramonti J., and Bueno L. Central and peripheral action of GABAA and GABAB agonists on small intestine motility in rats. Eur J Pharmacol 150 (1988) 163-169
33. Wood K., Addae J., Andrews P., and Stone T. Injection of baclofen into the ventromedial hypothalamus stimulates gastric motility in the rat. Neuropharmacology 26 (1987) 1191-1194
34. Andrews P., and Wood K. Systemic baclofen stimulates gastric motility and secretion via a central action in the rat. Br J Pharmacol 89 (1986) 461-467
35. Lehmann A., Bremner-Danielsen M., Brändén L., and Kärrberg L. Effects of GABA B receptor agonists on swallowing in the dog. Eur J Pharmacol 448 (2003) 67-70